CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company, announced new executive appointments to lead the company’s strategy and business development as well as global sales.
Nikko Khazana will serve as NantHealth’s Senior Vice President for Strategy and Business Development. Mark Mozley takes on the role of Senior Vice President for Global Sales at the company.
Khazana brings more than 25 years working in corporate strategy, business development, sales and marketing to his new role at NantHealth. As Senior Vice President for Strategy and Business Development, Khazana will play a crucial role in identifying growth opportunities for GPS Cancer® to drive global business growth, financial performance and strategy execution for the entire NantHealth healthcare solutions portfolio.
Prior to joining NantHealth, Khazana held senior executive management positions in strategy, sales, marketing, and operations at IQVIA, Integra Connect, CompanionDx Reference Lab, Cardinal Health Specialty, AmerisourceBergen Specialty, and Tyco International.
Mozley brings more than 15 years of experience leading sales organizations in both the United States and abroad to his new role as Senior Vice President for Global Sales. He joins from Clarivate Analytics, a global data and analytics company, where he led the firm’s life sciences and global strategic accounts teams. Mozley brings expertise across the pharmaceutical sector with experience in bioinformatics, competitive intelligence, regulatory, and professional services.
“Nikko and Mark will bring innovative ideas and excitement around our products and services as we continue our global expansion in next-generation, evidence-based, personalized healthcare,” said Ron Louks, Chief Operating Officer for NantHealth. “These seasoned executives will elevate NantHealth’s product portfolio to the next level enabling accelerated market adoption and growth in the future.”
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a next-generation, evidence-base, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth’s focused portfolio exemplifies its unique systems-based approach to personalized healthcare and integrates novel analysis with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. For more information please visit www.nanthealth.com.
